Royce & Associates’s Kyndryl KD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$193K Sell
17,032
-420,496
-96% -$5.24M ﹤0.01% 724
2026
Q1
$5.74M Sell
437,528
-1,479,508
-77% -$26M 0.06% 442
2025
Q4
$50.9M Buy
1,917,036
+186,620
+11% +$5.06M 0.52% 32
2025
Q3
$52M Buy
1,730,416
+274,532
+19% +$9.43M 0.52% 28
2025
Q2
$61.1M Sell
1,455,884
-97,594
-6% -$3.53M 0.63% 19
2025
Q1
$48.8M Sell
1,553,478
-777,246
-33% -$29.1M 0.53% 30
2024
Q4
$80.6M Sell
2,330,724
-312,604
-12% -$9.1M 0.75% 12
2024
Q3
$60.7M Buy
2,643,328
+232,583
+10% +$5.67M 0.55% 31
2024
Q2
$63.4M Sell
2,410,745
-184,026
-7% -$4.41M 0.59% 27
2024
Q1
$56.5M Sell
2,594,771
-193,515
-7% -$4.12M 0.5% 32
2023
Q4
$57.9M Sell
2,788,286
-379,932
-12% -$6.49M 0.54% 31
2023
Q3
$47.8M Buy
3,168,218
+302,734
+11% +$4.49M 0.49% 41
2023
Q2
$38.1M Buy
2,865,484
+953,261
+50% +$12.9M 0.37% 58
2023
Q1
$28.2M Sell
1,912,223
-270,903
-12% -$3.84M 0.28% 83
2022
Q4
$24.3M Buy
2,183,126
+56,968
+3% +$573K 0.26% 99
2022
Q3
$17.6M Buy
+2,126,158
New +$22.1M 0.2% 131

Other funds holding KD

Royce & Associates's KD Position: Q2 2026 in Review

Royce & Associates reduced its Kyndryl (KD) stake by 96% in Q2 2026, selling an estimated $5.24M and leaving 17,032 shares worth $193K. The position accounts for ﹤0.01% of the portfolio, ranked #724.

Royce & Associates first reported a position in KD in Q3 2022 and has held it in 16 quarters since. The position peaked at $80.6M in Q4 2024. 671 funds tracked by Wall St. Rank hold KD as of Q2 2026.

  • Royce & Associates held 17,032 shares of Kyndryl worth $193K as of Q2 2026.
  • Royce & Associates sold 420,496 Kyndryl shares in Q2 2026, an estimated $5.24M.
  • Kyndryl made up ﹤0.01% of Royce & Associates's portfolio in Q2 2026, its #724 holding.
  • Royce & Associates first reported a position in Kyndryl in Q3 2022 and has held it in 16 quarters since.
  • Royce & Associates's Kyndryl position peaked at $80.6M in Q4 2024.
  • 671 funds tracked by Wall St. Rank held Kyndryl as of Q2 2026.

Based on Royce & Associates's 13F filing for Q2 2026, filed 14 Aug 2026.